MeSH term
Frequency | Condition_Probility | Animals | 24 | 0.0 |
Humans | 50 | 0.0 |
Mice | 15 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Jurkat Cells | 14 | 1.0 |
Mice, Transgenic | 2 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 6 | 0.0 |
Receptor-CD3 Complex, Antigen, T-Cell/*immunology | 2 | 15.0 |
Receptors, Antigen, T-Cell/*immunology | 2 | 1.0 |
Research Support, Non-U.S. Gov't | 28 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Signal Transduction | 9 | 0.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
Amino Acid Sequence | 11 | 0.0 |
COS Cells | 4 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Phosphorylation | 14 | 0.0 |
Point Mutation | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 3 | 4.0 |
Receptors, Antigen, T-Cell/metabolism | 2 | 1.0 |
Tyrosine/metabolism | 5 | 0.0 |
src Homology Domains | 4 | 0.0 |
*Cell Cycle Proteins | 3 | 0.0 |
Enzyme Activation/immunology | 4 | 3.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Phospholipase C/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Signal Transduction/*immunology | 5 | 1.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Immunophenotyping | 3 | 0.0 |
Mitogen-Activated Protein Kinases/immunology | 2 | 28.0 |
Protein-Tyrosine Kinase/immunology | 2 | 16.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Cell Line | 6 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Calcium/metabolism | 4 | 0.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Killer Cells, Natural/*immunology | 4 | 0.0 |
Phosphotyrosine/metabolism | 4 | 0.0 |
Signal Transduction/immunology | 4 | 1.0 |
Transfection | 8 | 0.0 |
Lymphocyte Activation/*immunology | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 5 | 0.0 |
Receptors, Antigen, T-Cell/*physiology | 4 | 2.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Signal Transduction | 4 | 0.0 |
Cells, Cultured | 3 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
Time Factors | 6 | 0.0 |
Female | 4 | 0.0 |
Male | 9 | 0.0 |
Middle Aged | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Protein Binding | 4 | 0.0 |
Vanadates/pharmacology | 3 | 2.0 |
Carrier Proteins/metabolism/physiology | 2 | 25.0 |
Receptor-CD3 Complex, Antigen, T-Cell/physiology | 2 | 7.0 |
Lymphocyte Activation | 2 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
CD4-Positive T-Lymphocytes/metabolism | 2 | 1.0 |
CD8-Positive T-Lymphocytes/*metabolism | 2 | 5.0 |
Cell Cycle Proteins/*genetics/metabolism | 2 | 3.0 |
*Drosophila Proteins | 2 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
Heat-Shock Proteins 90/metabolism | 2 | 6.0 |
Models, Genetic | 2 | 0.0 |
*Molecular Chaperones | 2 | 1.0 |
*Mutation, Missense | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Protein-Tyrosine Kinase/*genetics/*metabolism | 3 | 14.0 |
Severe Combined Immunodeficiency/*genetics | 2 | 8.0 |
Temperature | 2 | 0.0 |
Molecular Weight | 4 | 0.0 |
Rats | 4 | 0.0 |
Adult | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Protein-Tyrosine Kinase/chemistry/*physiology | 2 | 22.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
src-Family Kinases/metabolism | 4 | 2.0 |
Tyrosine/*metabolism | 2 | 0.0 |
Clone Cells | 3 | 0.0 |
Interleukin-2/biosynthesis | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Signal Transduction/*physiology | 4 | 0.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 4 | 1.0 |
Protein-Tyrosine Kinase/*immunology | 2 | 13.0 |
Mice, Inbred C57BL | 3 | 0.0 |
T-Lymphocytes/*enzymology | 2 | 3.0 |
*Lymphocyte Activation | 3 | 0.0 |
Phosphotyrosine | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Receptors, Antigen, T-Cell/physiology | 2 | 1.0 |
NF-kappa B/metabolism | 2 | 0.0 |
